Medicenna Therapeutics Corp. (TSE:MDNA – Get Free Report)’s share price rose 4.6% during trading on Friday . The stock traded as high as C$0.92 and last traded at C$0.91. Approximately 4,855 shares were traded during mid-day trading, a decline of 91% from the average daily volume of 51,231 shares. The stock had previously closed at C$0.87.
Medicenna Therapeutics Trading Up 4.6%
The company has a quick ratio of 4.65, a current ratio of 11.40 and a debt-to-equity ratio of 0.88. The firm has a 50 day moving average of C$1.02 and a 200 day moving average of C$1.25. The firm has a market cap of C$68.08 million, a PE ratio of -2.51 and a beta of 1.21.
About Medicenna Therapeutics
Medicenna Therapeutics Corp is a Canada based immuno-oncology company. Its principal business activity is the development and commercialization of Empowered Cytokines and Superkines for the treatment of cancer. The company is engaged in developing Interleukin-4 Empowered Cytokines that specifically target the Interleukin-4 Receptor which is over-expressed by 20 different cancers, cancer stem cells and immunosuppressive cells of the tumor microenvironment.
Featured Articles
- Five stocks we like better than Medicenna Therapeutics
- Insider Buying Explained: What Investors Need to Know
- X: 1 Reason to Bet on U.S. Steel, and 1 Reason to Hold Back
- What does consumer price index measure?
- 3 Oversold Stocks Flashing Bullish Reversal Signals
- 3 Must-Buy Warren Buffett Stocks for Volatile Times
- With Novo Nordisk’s CEO Out, Wall Street Wants an American Leader
Receive News & Ratings for Medicenna Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medicenna Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
